This differs than other study done by Wang et al., 2013 in China on 20 AML cases on top of CML, higher level of SALL4 expression was associated with worse survival rates and SALL4 level decreased following effective therapy (P<0.05). The gene discussed is SALL4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.